Galectin Therapeutics Inc
GALT· Nasdaq
GALTGalectin Therapeutics Inc
Filed Nov 12, 2013 · 10-Q · 43 days after period end · 0001193125-13-437143
| Metric | Q3 2013 | Q3 2012 | Q3 2011 | Q3 2010 |
|---|---|---|---|---|
| Net Income | -$3.54M | -$2.69M | -$2.03M | -$1.11M |
| EPS Diluted | -$0.22 | -$0.19 | -$0.19 | -$0.03 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Galectin Therapeutics Inc · CIK 1133416 · Engraved from SEC EDGAR
ended Sep 30, 2013 · filed Nov 12, 2013 · 43 d after period end
